[HTML][HTML] Metformin: current clinical applications in nondiabetic patients with cancer

K Chen, Y Li, Z Guo, Y Zeng, W Zhang… - Aging (Albany NY …, 2020 - ncbi.nlm.nih.gov
Metformin is one of the most commonly used first-line oral medications for type 2 diabetes
mellitus. Multiple observational studies, reviewed in numerous systematic reviews, have …

[HTML][HTML] Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

MK Crist, B Yaniv, S Palackdharry… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Original research: Metformin increases natural killer cell functions in head and neck squamous
cell carcinoma through CXCL1 inhibition - PMC Back to Top Skip to main content NIH NLM …

The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies

M Abdelmoneim, MA Aboalela, Y Naoe… - International Journal of …, 2023 - mdpi.com
The tumor microenvironment (TME) plays a pivotal role in the fate of cancer cells, and tumor-
infiltrating immune cells have emerged as key players in shaping this complex milieu …

Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review

S Fakhri, SZ Moradi, A Ash-Rafzadeh… - Pharmacological …, 2022 - Elsevier
Senescence suppresses tumor growth, while also developing a tumorigenic state in the
nearby cells that is mediated by senescence-associated secretory phenotypes (SASPs). The …

COVID-19. Pandemic surgery guidance

BLDM Brücher, G Nigri, A Tinelli, J Florencio… - 4 OPEN, 2020 - iris.uniroma1.it
Based on high quality surgery and scientific data, scientists and surgeons are committed to
protecting patients as well as healthcare staff and hereby provide this Guidance to address …

Metformin as a therapeutic target in endometrial cancers

TY Lee, UE Martinez-Outschoorn, RJ Schilder… - Frontiers in …, 2018 - frontiersin.org
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its
increasing incidence is thought to be related in part to the rise of metabolic syndrome, which …

The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors

S Mostafavi, H Zalpoor, ZM Hassan - Cellular & molecular biology letters, 2022 - Springer
Tumor-infiltrated lymphocytes are exposed to many toxic metabolites and molecules in the
tumor microenvironment (TME) that suppress their anti-tumor activity. Toxic metabolites …

European Laryngological Society position paper on laryngeal dysplasia Part II: diagnosis, treatment, and follow-up

HE Eckel, R Simo, M Quer, E Odell, V Paleri… - European Archives of …, 2021 - Springer
Purpose of review To give an overview of the current knowledge regarding the diagnosis,
treatment, and follow-up of laryngeal dysplasia (LD) and to highlight the contributions of …

MALDI-MSI analysis of cancer drugs: Significance, advances, and applications

Q He, C Sun, J Liu, Y Pan - TrAC Trends in Analytical Chemistry, 2021 - Elsevier
Because of the heterogeneity and complexity of tumor structure, cancer drugs often cannot
effectively reach the tumor, which is one of the reasons for drug resistance and treatment …

[HTML][HTML] Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects

R Veeramachaneni, W Yu, JM Newton… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Metformin is a commonly used antidiabetic medication which has demonstrated
promise as an anticancer agent alone and in combination with conventional treatment …